Potassium Binders in Heart Failure: Who, When, and How
Host: Ileana L. Piña, MD, MPH, FAHA, FACC
Guest: Patrick Rossignol, MD, PhD
Clinicians often struggle to optimize guideline-directed medical therapy in patients with heart failure and frequently lower RAASi therapies in response to episodes of hyperkalemia, which translates into an increased risk for poor outcomes. But what if there was a better way to lower potassium levels so that these patients could reach those target doses?
This activity will cover the screening and monitoring strategies for hyperkalemia in patients with heart failure as well as how to utilize newer potassium binders to maximize guideline-recommended RAASi therapy.